Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists probe why women get this rare lung disease more than men

NCT ID NCT01884051

Summary

This research aims to better understand the underlying causes of pulmonary arterial hypertension (PAH), a serious lung and heart condition. The study will investigate why women are affected more often than men by examining hormone levels, the role of insulin resistance, and testing a potential drug (recombinant ACE2) in animal models. It involves observing and measuring factors in about 1,900 participants with PAH or at risk for it, with the goal of guiding future treatment development.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Vanderbilt University Medical Center

    RECRUITING

    Nashville, Tennessee, 37232, United States

Conditions

Explore the condition pages connected to this study.